Frailty and muscle loss in chronic lung disease
Part of Brain & nervous system, Immune system & allergy, Lungs & breathing clinical trials.
This study looks at people with COPD or ILD who also show signs of frailty. It aims to understand how frailty and muscle loss (sarcopenia) affect their care and use of medical resources over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) and are seeing a lung doctor as an outpatient (not in the hospital).
- You are considered frail based on a standard frailty scale (for example, you feel weak, have slow walking speed, or low energy).
- You are willing to give your ID number so the study team can access your health records from the National Health Insurance database.
- You are 20 years of age or older.
- You are able to walk on your own (not bedridden or unable to walk due to a physical disability).
- You do not have terminal cancer or HIV/AIDS.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding a dietary supplement to exercise can improve muscle strength in people with muscle loss (sarcopenia) who also have lung disease such as COPD or ILD. It may help you build strength and function without needing urgent hospital care.
This study looks at how frailty (a state of being more vulnerable to health problems) affects people with scarring lung diseases. It aims to understand if frailty can help predict how the disease will progress and how treatments might be adjusted.
This study looks at how frailty affects the course of chronic diseases and how chronic diseases affect frailty. It may help understand aging-related conditions better.
This study tests a new clinic designed to help people with COPD who have lost muscle mass (sarcopenia). By using a CT scan done during your hospital stay, doctors can identify muscle loss and offer treatments to help you regain strength and function.
This trial looks at ways to help “frailty” (low strength and resilience) in people staying in intensive care units. It mainly enrolls adults who expect to be in the ICU for more than 24 hours, and it tries to avoid people whose mobility problems have other causes.
This study looks at how common it is to have both COPD (a chronic lung disease) and sarcopenic obesity (loss of muscle with excess body fat). By joining, you'll help doctors understand this condition better and may get a full health check-up.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.